Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

XON / MEDS:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
ghmm Member Profile
Member Level 
Followed By 43
Posts 5,533
Boards Moderated 0
Alias Born 01/22/06
160x600 placeholder
ghmm Member Level  Friday, 12/20/13 02:33:34 PM
Re: ghmm post# 171419
Post # of 182063 
XON / MEDS:

Intrexon to Acquire Medistem to Generate Multipotent Cells


Medistem's Stem Cell Technology to be Integrated Into Intrexon's Proprietary Synthetic Biology Platform

http://finance.yahoo.com/news/intrexon-acquire-medistem-generate-multipotent-154433543.html

I don't follow Intrexon and don't really know what Kirk means by synthetic biology sure seems he has done a wide array of (albeit smaller) deals I don't follow the connection(s) though.

Quote:

...to acquire, for approximately $26 million, San Diego-based Medistem, Inc. (MEDS) a pioneer in the development of Endometrial Regenerative Cells ... Pursuant to the definitive agreement, Medistem stockholders will receive in exchange for each share of Medistem common stock $0.27 in cash and $1.08 worth of Intrexon common stock, based on the 20-day volume-weighted average price of Intrexon's common stock immediately prior to closing.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist